Terms: = Ovarian cancer AND FOXP1, MGC12942, 27086, ENSG00000114861, hFKH1B, MGC99551, FLJ23741, QRF1, 12CC4, HSPC215, MGC88572 AND Treatment
5 results:
1. Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib.
Eismann J; Heng YJ; Waldschmidt JM; Vlachos IS; Gray KP; Matulonis UA; Konstantinopoulos PA; Murphy CJ; Nabavi S; Wulf GM
J Cancer Res Clin Oncol; 2020 Feb; 146(2):503-514. PubMed ID: 31745703
[TBL] [Abstract] [Full Text] [Related]
2. Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy.
Ricci F; Fratelli M; Guffanti F; Porcu L; Spriano F; Dell'Anna T; Fruscio R; Damia G
Oncotarget; 2017 Jan; 8(5):7441-7451. PubMed ID: 26910918
[TBL] [Abstract] [Full Text] [Related]
3. foxp1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
[TBL] [Abstract] [Full Text] [Related]
4. Gene expression profile analysis identifies metastasis and chemoresistance-associated genes in epithelial ovarian carcinoma cells.
Zhu L; Hu Z; Liu J; Gao J; Lin B
Med Oncol; 2015 Jan; 32(1):426. PubMed ID: 25502083
[TBL] [Abstract] [Full Text] [Related]
5. Identification of differentially expressed genes using an annealing control primer system in stage III serous ovarian carcinoma.
Kim YS; Hwan JD; Bae S; Bae DH; Shick WA
BMC Cancer; 2010 Oct; 10():576. PubMed ID: 20969748
[TBL] [Abstract] [Full Text] [Related]
